United Kingdom, January 09, 2018: The European Medical Journal is bringing the New Year in with a bang with the publication of EMJ Innovations 2.1. This edition is packed with all the most exciting upcoming medical innovations and ongoing research with a fantastic review of MEDICA 2017, which had a whopping 123,500 professionals attend from around the world. Reported to be the world’s biggest world-leading specialist trade fair for the medical technology industry, MEDICA proved, yet again, to be a truly inspiring meeting. Just some of the fantastic advances announced at the event are described within EMJ Innovations 2.1.
Alongside this comprehensive review are some intriguing insights into the world of medical innovations in our interview section. Four of the esteemed EMJ Innovations Editorial Board members discuss their current research, hopes for the future, and reflect on their careers giving helpful hints for those who might wish to follow in their footsteps. These inspiring conversations are the perfect feature for young medical students or experienced clinicians looking to gain a new viewpoint on some of the big challenges being faced by healthcare professionals across the globe.
The peer-reviewed articles included in EMJ Innovations 2.1 form the pinnacle of cutting-edge research. The Editor’s Pick, penned by Rygiel, focusses on cardiac remodelling following myocardial infarction. The article dives into the characteristics and use of Algisyl®, an injectable biomaterial-based therapy, whilst providing intense discussion into the AUGMENT-HF trial, in which the new therapy technique was examined. One of the many articles to complement this is McGrath’s review, which contains a highly informative exploration of ‘omics’ in the context of precision medicine. As therapeutics are increasingly being refined and enhanced with the passion to seek improvements in patient care, McGrath hits the nail on the head with this topical review. Available now: https://www.emjreviews.com/journals/emj-innovations-2-1-2018/
The European Medical Journal hopes that EMJ Innovations 2.1 will inspire the medical community and promote discussion for months to come. Spencer Gore, Director of the European Medical Group, expressed his enthusiasm for the publication: “EMJ is proud to present the second edition of EMJ Innovations. The passion and determination of researchers from around the globe shines through in this eJournal, and I hope that readers will enjoy reading the contents as much as we have enjoyed producing them.” For even more up-to-the-minute content on medical innovations and other therapeutic areas, connect with European Medical Journal on Facebook, Twitter, LinkedIn, and Google+.
-END-
About the European Medical Journal
The European Medical Journal is an independent company that annually produces a collection of open-access medical eJournals covering therapeutic areas such as Respiratory, Gastroenterology, Cardiology, and Urology. By combining editorials from key opinion leaders with concise news coverage from the leading congresses within the medical industry, we aim to deliver first-class insight into ground-breaking changes and advances in medicine. The production of our high-quality, peer-reviewed eJournals, and our collaborations with independent clinical bodies result in a dynamic and contemporary tool with which to assist industry professionals across Europe in progressively developing their performance and efficacy.
Media Contact
Name: Stacey Rivers
Number: 01245 334452
E-mail: [email protected]
